Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy
T. Lissitchkov, G. Arnaudov, D. Peytchev, Kh. MerkleVolume:
132
Langue:
english
Pages:
6
DOI:
10.1007/s00432-005-0050-z
Date:
February, 2006
Fichier:
PDF, 183 KB
english, 2006